Both in Pharmaceuticals
Zymeworks vs Trulieve Cannabis
Over the past year ZYME returned +17.9% and TRLV returned +2.6%; their daily moves had a correlation of 0.63.
ZYME +17.9% TRLV +2.6%Growth of $1, one year, split-adjusted
| Metric | ZYME | TRLV |
|---|---|---|
| Price | $30.94 | $11.60 |
| Market cap | $2.22B | $2.23B |
| Today | +2.69% | +0.52% |
| 1 month | +20.6% | +8.9% |
| 6 months | +12.1% | — |
| Year to date | +17.5% | — |
| 1 year | +63.8% | — |
| Revenue growth (YoY) | −90.6% | — |
| Gross margin | 100.0% | 59.9% |
| Net margin | −980.8% | −149.8% |
| P/E (TTM) | — | — |
| Price / sales | 59.9× | — |
| Net cash | $270.7M | -$154.8M |
| Dividend yield | — | — |
| Volatility (60d) | 47.0% | — |
| Short % of float | 12.5% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).